Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage
MNEMONICH
1 other identifier
observational
40
0 countries
N/A
Brief Summary
The aim of this project is development of a comprehensive, prospective, multinational, multicenter, hospital-based, data repository for patients with intracerebral hemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2015
CompletedFirst Posted
Study publicly available on registry
October 2, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedDecember 9, 2016
December 1, 2016
9 months
September 30, 2015
December 8, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Rankin Scale score
90 days
Eligibility Criteria
Patients hospitalized for ICH will be asked to provide their permission for the use of this information for retrospective research studies directed at ICH; such research to be conducted by the MNEMONICH investigators.
You may qualify if:
- Diagnosis of spontaneous intracerebral hemorrhage (ICH) met by clinical and imaging criteria
- Age 18 and above
- Able to consent
You may not qualify if:
- ICH due to trauma
- ICH due to vascular malformation or aneurysm
- ICH due to brain tumor
- ICH due to underlying infectious lesion (e.g., abscess)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Texas Health Science Center at San Antoniolead
- Centre for Cardiovascular Medicine and Cerebrovascular Disease Preventioncollaborator
- Hospital Interzonal de Agudos San Juan Bautistacollaborator
- Maastricht University Medical Centercollaborator
- University of Western Ontario, Canadacollaborator
- Northern Care Alliance NHS Foundation Trustcollaborator
- University of Manchestercollaborator
- University of Rostockcollaborator
- University of Medicine and Pharmacy Craiovacollaborator
- San Camillo de' Lellis General Hospitalcollaborator
- Azienda USL Reggio Emilia - IRCCScollaborator
- University of Central Floridacollaborator
- Manchester Metropolitan Universitycollaborator
Related Publications (1)
Behrouz R, Azarpazhooh MR, Godoy DA, Hoffmann MW, Masotti L, Parry-Jones AR, Popa-Wagner A, Schreuder FH, Slevin MA, Smith CJ, Di Napoli M; MNEMONICH Steering Committee. The Multi-National survey on Epidemiology, Morbidity, and Outcomes iN Intracerebral Haemorrhage (MNEMONICH). Int J Stroke. 2015 Dec;10(8):E86. doi: 10.1111/ijs.12629. No abstract available.
PMID: 26745705BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mario Di Napoli, MD
Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention
- PRINCIPAL INVESTIGATOR
Mahmoud R Azarpazhooh, MD
Western University, Canada
- PRINCIPAL INVESTIGATOR
Reza Behrouz, DO
The University of Texas Health Science Center at San Antonio
- PRINCIPAL INVESTIGATOR
Luca Masotti, MD
Azienda USL Reggio Emilia - IRCCS
- PRINCIPAL INVESTIGATOR
Adrian R Parry-Jones, MBChB, PhD
University of Manchester and the Salford Royal NHS Foundation Trust
- PRINCIPAL INVESTIGATOR
Aurel Popa-Wagner, MD, PhD
University of Rostock
- PRINCIPAL INVESTIGATOR
Mark A Slevin, PhD
Manchester Metropolitan University
- PRINCIPAL INVESTIGATOR
Craig J Smith, MBChB, MD
University of Manchester and the Salford Royal NHS Foundation Trust
- PRINCIPAL INVESTIGATOR
Daniel A Godoy, MD
Hospital Interzonal de Agudos San Juan Bautista
- PRINCIPAL INVESTIGATOR
Floris H Schreuder, MD
Maastricht University Medical Center
- PRINCIPAL INVESTIGATOR
Michael W Hoffmann, MBChB, PhD
University of Central Florida
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 90 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 30, 2015
First Posted
October 2, 2015
Study Start
November 1, 2015
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
December 9, 2016
Record last verified: 2016-12